[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "fullTimeEmployees": 146, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 76, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 136945, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 51, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 677235, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 340170, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Vice President of Market & Market Access", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inge  Vanwittenbergh", "title": "Global Human Resource Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. DeMartino", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.82, "open": 10.0, "dayLow": 9.63, "dayHigh": 10.305, "regularMarketPreviousClose": 9.82, "regularMarketOpen": 10.0, "regularMarketDayLow": 9.63, "regularMarketDayHigh": 10.305, "beta": 0.477, "forwardPE": -4.692308, "volume": 21039, "regularMarketVolume": 21039, "averageVolume": 46356, "averageVolume10days": 21530, "averageDailyVolume10Day": 21530, "marketCap": 282196736, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 20.0, "priceToSalesTrailing12Months": 64.90266, "fiftyDayAverage": 13.12748, "twoHundredDayAverage": 8.5324, "currency": "USD", "enterpriseValue": 234898512, "floatShares": 10975984, "sharesOutstanding": 28682600, "sharesShort": 268182, "sharesShortPriorMonth": 290893, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0094, "heldPercentInsiders": 0.49181, "heldPercentInstitutions": 0.23683001, "shortRatio": 5.61, "shortPercentOfFloat": 0.021300001, "bookValue": 3.418, "priceToBook": 2.8554711, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -43212000, "trailingEps": -1.66, "forwardEps": -2.08, "enterpriseToRevenue": 54.024, "enterpriseToEbitda": -5.284, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.76, "targetHighPrice": 27.02, "targetLowPrice": 18.02, "targetMeanPrice": 21.41, "targetMedianPrice": 20.02, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 57748000, "totalCashPerShare": 2.013, "ebitda": -44458000, "totalDebt": 12704000, "quickRatio": 4.388, "currentRatio": 4.732, "totalRevenue": 4348000, "debtToEquity": 12.96, "revenuePerShare": 0.155, "returnOnAssets": -0.20863001, "returnOnEquity": -0.39581, "freeCashflow": -40092376, "operatingCashflow": -44778000, "revenueGrowth": 0.396, "grossMargins": 0.61914, "operatingMargins": -5.9413395, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-05-04"}]